Atlas Cycles (ATLASCYCLE)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a deep discount to book value: ₹105.12 against ₹597.47 per share, P/B of 0.18.
• Balance sheet is almost debt-free with Debt/Equity of 0.02, reducing insolvency risk.
• Promoter holding of 41.92% provides some alignment with minority shareholders.
• ROCE of 2.27% is positive, suggesting capital employed is not completely loss-making yet.

Concerns

• Sales growth is -30.91%, and latest quarterly sales of ₹2 Cr are alarmingly low.
• Latest quarter net loss of ₹2 Cr and profit growth of -655.56% show ongoing deterioration.
• Negative ROE of -1.16% and Piotroski F-Score of 3/9 reflect weak financial health.
• Zero dividend yield means investors get no income while waiting for a recovery.

AI Analysis

Let me start with the obvious: this is not a business I would normally want to own. Atlas Cycles has sales growth of -30.91%, and its latest quarter shows ₹2 crore in sales against a ₹2 crore net loss. The company is losing money, P/E is meaningless, and the Piotroski F-Score of 3/9 tells me the financial health is weak. ROE is negative at -1.16%, so the huge book value is not earning anything for shareholders. That book value is the only interesting thing: at ₹597.47 per share, the stock trades at ₹105.12, a price-to-book of 0.18. The market is effectively saying the assets are worth only about 18 paise per rupee. Is that a margin of safety or a value trap? Graham would ask whether that book value is real and how quickly it can be converted. The balance sheet is almost debt-free with debt/equity 0.02, which does give some cushion. Promoter holding at 41.92% is meaningful, but at this level of losses, even low leverage won't protect equity if sales keep collapsing. I cannot rely on earnings growth; there are none. This is an asset play, not a franchise. If management can stabilize sales, cut losses, and extract value from the balance sheet, there is upside; if not, the discount to book can persist or even widen. I would need a catalyst and evidence that the ₹597 book value is not impaired. Until then, this is a small, speculative cigar butt, not a compounder.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer